APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study
Lp(a), called the holy grail of prevention research, was reduced dramatically with SLN360 and should spur further research.
Source: tctmd.com
Stay updated with breaking news from Other Agents In Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lp(a), called the holy grail of prevention research, was reduced dramatically with SLN360 and should spur further research.